Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1993 Mar;35(3):235–242. doi: 10.1111/j.1365-2125.1993.tb05690.x

Equipotent inhibition by R(-)-, S(+)- and racemic ibuprofen of human polymorphonuclear cell function in vitro.

M Villanueva 1, R Heckenberger 1, H Strobach 1, M Palmér 1, K Schrör 1
PMCID: PMC1381568  PMID: 8385973

Abstract

1. The effects of racemic (rac) ibuprofen and its S(+)- and R(-)-enantiomers on functions of human polymorphonuclear cells (PMN) and platelets were studied in vitro. 2. Rac-ibuprofen inhibited PMN functions (O2- generation, beta-glucuronidase release, LTB4 formation). Similar IC50 values (40-100 microM) were obtained for the S(+)- and R(-)-enantiomers. 3. All forms of ibuprofen inhibited cyclooxygenase-related platelet functions (aggregation, thromboxane formation). The S(+)-enantiomer was about twice as active as the racemate while the R(-)-enantiomer was at least 10-fold less active. This demonstrates that the S(+) is the only cyclooxygenase inhibitory component of the racemate. 4. The concentrations of rac-ibuprofen in PMN and platelets were similar to those in the incubation medium and represented equal concentrations of the enantiomers. This indicates that neither interconversion nor tissue accumulation of the compounds occurred. 5. These data indicate that antineutrophil effects of ibuprofen on human PMN are independent of cyclooxygenase inhibition. Therefore, R(-)-ibuprofen may be superior to the S(+)-isomer for the treatment of PMN-dependent inflammatory diseases. However, effective free drug concentrations may not be obtained in vivo.

Full text

PDF
235

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson S. B., Leszczynska-Piziak J., Haines K., Reibman J. Non-steroidal anti-inflammatory drugs: effects on a GTP binding protein within the neutrophil plasma membrane. Biochem Pharmacol. 1991 Jun 1;41(11):1567–1573. doi: 10.1016/0006-2952(91)90155-x. [DOI] [PubMed] [Google Scholar]
  2. Abramson S., Korchak H., Ludewig R., Edelson H., Haines K., Levin R. I., Herman R., Rider L., Kimmel S., Weissmann G. Modes of action of aspirin-like drugs. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7227–7231. doi: 10.1073/pnas.82.21.7227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Adams S. S., Bresloff P., Mason C. G. Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-)-isomer. J Pharm Pharmacol. 1976 Mar;28(3):256–257. doi: 10.1111/j.2042-7158.1976.tb04144.x. [DOI] [PubMed] [Google Scholar]
  4. Ali A. T., Hanson J. M., Morley J. Effects of non-steroidal anti-inflammatory drugs on lymphocyte activation. Agents Actions. 1984 Feb;14(2):216–222. doi: 10.1007/BF01966645. [DOI] [PubMed] [Google Scholar]
  5. Babior B. M., Kipnes R. S., Curnutte J. T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest. 1973 Mar;52(3):741–744. doi: 10.1172/JCI107236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bradley J. D., Brandt K. D., Katz B. P., Kalasinski L. A., Ryan S. I. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med. 1991 Jul 11;325(2):87–91. doi: 10.1056/NEJM199107113250203. [DOI] [PubMed] [Google Scholar]
  7. Chen C. S., Shieh W. R., Lu P. H., Harriman S., Chen C. Y. Metabolic stereoisomeric inversion of ibuprofen in mammals. Biochim Biophys Acta. 1991 Jul 12;1078(3):411–417. doi: 10.1016/0167-4838(91)90164-u. [DOI] [PubMed] [Google Scholar]
  8. Evans A. M., Nation R. L., Sansom L. N., Bochner F., Somogyi A. A. Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen. Br J Clin Pharmacol. 1991 Feb;31(2):131–138. doi: 10.1111/j.1365-2125.1991.tb05500.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fantone J. C., Kinnes D. A. Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophils. Biochem Biophys Res Commun. 1983 Jun 15;113(2):506–512. doi: 10.1016/0006-291x(83)91754-0. [DOI] [PubMed] [Google Scholar]
  10. Freneaux E., Fromenty B., Berson A., Labbe G., Degott C., Letteron P., Larrey D., Pessayre D. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids. J Pharmacol Exp Ther. 1990 Nov;255(2):529–535. [PubMed] [Google Scholar]
  11. Goldyne M. E. Eicosanoid metabolism by lymphocytes: do all human nucleated cells generate eicosanoids? Pharmacol Res. 1989 May-Jun;21(3):241–245. doi: 10.1016/s1043-6618(89)80001-5. [DOI] [PubMed] [Google Scholar]
  12. Hecker G., Ney P., Schrör K. Cytotoxic enzyme release and oxygen centered radical formation in human neutrophils are selectively inhibited by E-type prostaglandins but not by PGI2. Naunyn Schmiedebergs Arch Pharmacol. 1990 Apr;341(4):308–315. doi: 10.1007/BF00180656. [DOI] [PubMed] [Google Scholar]
  13. Kean W. F., Lock C. J., Howard-Lock H. E. Chirality in antirheumatic drugs. Lancet. 1991 Dec 21;338(8782-8783):1565–1568. doi: 10.1016/0140-6736(91)92382-c. [DOI] [PubMed] [Google Scholar]
  14. Kennedy T. P., Rao N. V., Noah W., Michael J. R., Jafri M. H., Jr, Gurtner G. H., Hoidal J. R. Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron. J Clin Invest. 1990 Nov;86(5):1565–1573. doi: 10.1172/JCI114876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kitsis E. A., Weissmann G., Abramson S. B. The prostaglandin paradox: additive inhibition of neutrophil function by aspirin-like drugs and the prostaglandin E1 analog misoprostol. J Rheumatol. 1991 Oct;18(10):1461–1465. [PubMed] [Google Scholar]
  16. Knihinicki R. D., Williams K. M., Day R. O. Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs--1. In vitro studies of ibuprofen and flurbiprofen. Biochem Pharmacol. 1989 Dec 15;38(24):4389–4395. doi: 10.1016/0006-2952(89)90647-3. [DOI] [PubMed] [Google Scholar]
  17. Lee E. J., Williams K., Day R., Graham G., Champion D. Stereoselective disposition of ibuprofen enantiomers in man. Br J Clin Pharmacol. 1985 May;19(5):669–674. doi: 10.1111/j.1365-2125.1985.tb02694.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lenhard G., Kieferndorf U., Berner G., Engels B., Vögtle-Junkert U. Pharmakokinetik und Bioäquivalenz von zwei Ibuprofen-Formulierungen. Arzneimittelforschung. 1990 Dec;40(12):1358–1362. [PubMed] [Google Scholar]
  19. Lennard M. S. Clinical pharmacology through the looking glass: reflections on the racemate vs enantiomer debate. Br J Clin Pharmacol. 1991 Jun;31(6):623–625. doi: 10.1111/j.1365-2125.1991.tb05583.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Maderazo E. G., Breaux S. P., Woronick C. L. Inhibition of human polymorphonuclear leukocyte cell responses by ibuprofen. J Pharm Sci. 1984 Oct;73(10):1403–1406. doi: 10.1002/jps.2600731020. [DOI] [PubMed] [Google Scholar]
  21. McCormack K., Brune K. Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy. Drugs. 1991 Apr;41(4):533–547. doi: 10.2165/00003495-199141040-00003. [DOI] [PubMed] [Google Scholar]
  22. Ney P., Schrör K. E-type prostaglandins but not iloprost inhibit platelet activating factor-induced generation of leukotriene B4 by human polymorphonuclear leukocytes. Br J Pharmacol. 1989 Jan;96(1):186–192. doi: 10.1111/j.1476-5381.1989.tb11799.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. O'Flaherty J. T., Kreutzer D. L., Ward P. A. Effect of prostaglandins E1, E2 and F2alpha on neutrophil aggregation. Prostaglandins. 1979 Feb;17(2):201–210. doi: 10.1016/0090-6980(79)90039-x. [DOI] [PubMed] [Google Scholar]
  24. Powell W. S. Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. Methods Enzymol. 1982;86:467–477. doi: 10.1016/0076-6879(82)86218-6. [DOI] [PubMed] [Google Scholar]
  25. Reilly I. A., FitzGerald G. A. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood. 1987 Jan;69(1):180–186. [PubMed] [Google Scholar]
  26. Romero A. J., Rackley R. J., Rhodes C. T. An evaluation of ibuprofen bioinversion by simulation. Chirality. 1991;3(5):418–421. doi: 10.1002/chir.530030507. [DOI] [PubMed] [Google Scholar]
  27. Sanins S. M., Adams W. J., Kaiser D. G., Halstead G. W., Baillie T. A. Studies on the metabolism and chiral inversion of ibuprofen in isolated rat hepatocytes. Drug Metab Dispos. 1990 Jul-Aug;18(4):527–533. [PubMed] [Google Scholar]
  28. Schrör K., Seidel H. Blood-vessel wall arachidonate metabolism and its pharmacological modification in a new in vitro assay system. Naunyn Schmiedebergs Arch Pharmacol. 1988 Feb;337(2):177–182. doi: 10.1007/BF00169246. [DOI] [PubMed] [Google Scholar]
  29. Simchowitz L., Mehta J., Spilberg I. Chemotactic factor-induced generation of superoxide radicals by human neutrophils: effect of metabolic inhibitors and antiinflammatory drugs. Arthritis Rheum. 1979 Jul;22(7):755–763. doi: 10.1002/art.1780220711. [DOI] [PubMed] [Google Scholar]
  30. Twomey B. M., Dale M. M. Cyclooxygenase-independent effects of non-steroidal anti-inflammatory drugs on the neutrophil respiratory burst. Biochem Pharmacol. 1992 Feb 4;43(3):413–418. doi: 10.1016/0006-2952(92)90557-y. [DOI] [PubMed] [Google Scholar]
  31. Wallace J. L., Keenan C. M., Granger D. N. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol. 1990 Sep;259(3 Pt 1):G462–G467. doi: 10.1152/ajpgi.1990.259.3.G462. [DOI] [PubMed] [Google Scholar]
  32. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]
  33. Williams K. M. Enantiomers in arthritic disorders. Pharmacol Ther. 1990;46(2):273–295. doi: 10.1016/0163-7258(90)90095-j. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES